Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
$1.14B |
| 2 |
AbbVie
ABBV
|
$537M |
| 3 |
T-Mobile US
TMUS
|
$504M |
| 4 |
Baidu
BIDU
|
$474M |
| 5 |
Kroger
KR
|
$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
$1.26B |
| 3 |
S
Sprint Corporation
S
|
$675M |
| 4 |
Nabors Industries
NBR
|
$638M |
| 5 |
Amgen
AMGN
|
$504M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Neurocrine Biosciences
NBIX
$13.8B
| $181M | 0.16% |
1,484,764
+765,382
| +106% | +$93.4M |
|
127
Charles River Laboratories
CRL
$7.85B
| $180M | 0.16% |
1,034,779
-302,609
| -23% | -$52.8M |
|
128
AstraZeneca
AZN
$254B
| $179M | 0.15% |
3,389,955
-394,951
| -10% | -$20.9M |
|
129
Waste Connections
WCN
$46.5B
| $176M | 0.15% |
1,875,036
-140,800
| -7% | -$13.2M |
|
130
Markel Group
MKL
$24.6B
| $175M | 0.15% |
189,351
-21,220
| -10% | -$19.6M |
|
131
Dollar General
DG
$24.2B
| $173M | 0.15% |
910,497
-252,303
| -22% | -$48.1M |
|
132
Estee Lauder
EL
$32.5B
| $171M | 0.15% |
907,030
+352,100
| +63% | +$66.4M |
|
133
Aon
AON
$80.4B
| $170M | 0.15% |
884,701
+692,500
| +360% | +$133M |
|
134
National Beverage
FIZZ
$3.84B
| $170M | 0.15% |
2,790,371
+143,075
| +5% | +$8.73M |
|
135
Zoetis
ZTS
$67.2B
| $169M | 0.15% |
1,235,216
-412,362
| -25% | -$56.5M |
|
136
Logitech
LOGI
$15.3B
| $167M | 0.14% |
2,561,444
+7,542
| +0.3% | +$492K |
|
137
Pinnacle West Capital
PNW
$10.6B
| $166M | 0.14% |
2,271,686
-981,200
| -30% | -$71.9M |
|
|
ZNGA
138
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $166M | 0.14% |
17,348,900
+177,900
| +1% | +$1.7M |
|
139
Tencent Music
TME
$37.9B
| $165M | 0.14% |
12,248,400
+9,559,300
| +355% | +$129M |
|
140
Rogers Communications
RCI
$19.2B
| $162M | 0.14% |
4,043,183
+551,800
| +16% | +$22.2M |
|
|
TIF
141
DELISTED
Tiffany & Co.
TIF
| $162M | 0.14% |
1,330,202
+813,812
| +158% | +$99.2M |
|
142
Intel
INTC
$105B
| $162M | 0.14% |
2,709,594
+1,113,300
| +70% | +$66.6M |
|
143
Wheaton Precious Metals
WPM
$46.8B
| $160M | 0.14% |
3,629,545
+395,421
| +12% | +$17.4M |
|
144
Pan American Silver
PAAS
$12.4B
| $158M | 0.14% |
5,203,609
-2,389,295
| -31% | -$72.6M |
|
145
Scotiabank
BNS
$77.7B
| $156M | 0.13% |
3,788,800
+358,900
| +10% | +$14.8M |
|
146
Twilio
TWLO
$16B
| $156M | 0.13% |
710,595
+657,800
| +1,246% | +$144M |
|
147
CME Group
CME
$96.5B
| $153M | 0.13% |
939,418
-856,811
| -48% | -$139M |
|
148
Altice USA
ATUS
$1.11B
| $152M | 0.13% |
6,727,209
-1,682,491
| -20% | -$37.9M |
|
149
Bausch Health
BHC
$2.73B
| $151M | 0.13% |
8,281,249
-5,121,100
| -38% | -$93.7M |
|
150
Chunghwa Telecom
CHT
$33.7B
| $151M | 0.13% |
3,844,860
+415,289
| +12% | +$16.3M |
|